Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Iran
Iran: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 54.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Iran, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Iran recorded 54.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in 2025. That is the highest value across all 18 years on record.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Iran peaked at 54.0% in 2025 and was at its lowest, 0.0%, in 2008.
That places Iran 153rd out of 194 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 0.0% | 0.0% | 0.0% | 10 |
| 2020s | 9.0% | 0.0% | 54.0% | 6 |
Countries ranked near Iran
- 151 Madagascar 56.0% compare
- 152 Slovenia 55.0% compare
- 153 Angola 54.0% compare
- 155 Azerbaijan 52.0% compare
- 156 Kazakhstan 49.0% compare
- 156 Chad 49.0% compare
More health data for Iran
- Heat deaths vs projected death rates 1,361 (2090)
- Un projection of annual infant deaths 1,070 (2100)
- Deaths in armed conflicts by region 3,509 (2026)
- Deaths in armed conflicts by country 3,509 (2026)
- Age population, age 18, male, interpolated 654,438 (2025)
- Age population, age 19, female, interpolated 606,752 (2025)
- Age population, age 09, male, interpolated 800,455 (2025)
- Population ages 15-64, total 64.14 million (2025)
- Population ages 15-64, male 69.5% (2025)
- Age population, age 17, male, interpolated 667,754 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Iran?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Iran was 54.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Iran?
- The highest recorded value was 54.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Iran?
- The lowest recorded value was 0.0% in 2008.
- How does Iran rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Iran ranks 153rd out of 194 countries with data for 2025.
- Where does this Iran data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).